nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolcapone—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.054	0.7	CbGbCtD
Tolcapone—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0231	0.3	CbGbCtD
Tolcapone—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000411	0.000446	CcSEcCtD
Tolcapone—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000409	0.000444	CcSEcCtD
Tolcapone—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000407	0.000441	CcSEcCtD
Tolcapone—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000404	0.000437	CcSEcCtD
Tolcapone—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000402	0.000435	CcSEcCtD
Tolcapone—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000402	0.000435	CcSEcCtD
Tolcapone—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.0004	0.000434	CcSEcCtD
Tolcapone—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.0004	0.000433	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000399	0.000433	CcSEcCtD
Tolcapone—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000396	0.000429	CcSEcCtD
Tolcapone—Pain—Cisplatin—peripheral nervous system neoplasm	0.000395	0.000428	CcSEcCtD
Tolcapone—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000394	0.000427	CcSEcCtD
Tolcapone—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.00039	0.000423	CcSEcCtD
Tolcapone—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000389	0.000422	CcSEcCtD
Tolcapone—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000388	0.00042	CcSEcCtD
Tolcapone—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000386	0.000419	CcSEcCtD
Tolcapone—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000386	0.000419	CcSEcCtD
Tolcapone—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000386	0.000419	CcSEcCtD
Tolcapone—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000386	0.000418	CcSEcCtD
Tolcapone—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000385	0.000417	CcSEcCtD
Tolcapone—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000384	0.000416	CcSEcCtD
Tolcapone—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000381	0.000413	CcSEcCtD
Tolcapone—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00038	0.000412	CcSEcCtD
Tolcapone—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000378	0.000409	CcSEcCtD
Tolcapone—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000378	0.000409	CcSEcCtD
Tolcapone—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000377	0.000408	CcSEcCtD
Tolcapone—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000376	0.000408	CcSEcCtD
Tolcapone—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000375	0.000406	CcSEcCtD
Tolcapone—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000374	0.000406	CcSEcCtD
Tolcapone—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000372	0.000403	CcSEcCtD
Tolcapone—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000372	0.000403	CcSEcCtD
Tolcapone—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000372	0.000403	CcSEcCtD
Tolcapone—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000372	0.000403	CcSEcCtD
Tolcapone—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000371	0.000402	CcSEcCtD
Tolcapone—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000369	0.0004	CcSEcCtD
Tolcapone—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000368	0.000399	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000366	0.000396	CcSEcCtD
Tolcapone—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000365	0.000396	CcSEcCtD
Tolcapone—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000365	0.000396	CcSEcCtD
Tolcapone—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000365	0.000395	CcSEcCtD
Tolcapone—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000363	0.000393	CcSEcCtD
Tolcapone—Constipation—Etoposide—peripheral nervous system neoplasm	0.000362	0.000392	CcSEcCtD
Tolcapone—Pain—Etoposide—peripheral nervous system neoplasm	0.000362	0.000392	CcSEcCtD
Tolcapone—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000362	0.000392	CcSEcCtD
Tolcapone—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000361	0.000391	CcSEcCtD
Tolcapone—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000359	0.000389	CcSEcCtD
Tolcapone—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000359	0.000389	CcSEcCtD
Tolcapone—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000358	0.000388	CcSEcCtD
Tolcapone—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000357	0.000387	CcSEcCtD
Tolcapone—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000357	0.000387	CcSEcCtD
Tolcapone—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000355	0.000385	CcSEcCtD
Tolcapone—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000351	0.00038	CcSEcCtD
Tolcapone—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000349	0.000379	CcSEcCtD
Tolcapone—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000349	0.000378	CcSEcCtD
Tolcapone—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000349	0.000378	CcSEcCtD
Tolcapone—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000348	0.000377	CcSEcCtD
Tolcapone—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000346	0.000375	CcSEcCtD
Tolcapone—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000346	0.000375	CcSEcCtD
Tolcapone—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000346	0.000375	CcSEcCtD
Tolcapone—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000345	0.000374	CcSEcCtD
Tolcapone—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000344	0.000373	CcSEcCtD
Tolcapone—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000344	0.000373	CcSEcCtD
Tolcapone—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000342	0.000371	CcSEcCtD
Tolcapone—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000342	0.00037	CcSEcCtD
Tolcapone—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000341	0.000369	CcSEcCtD
Tolcapone—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.00034	0.000369	CcSEcCtD
Tolcapone—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00034	0.000368	CcSEcCtD
Tolcapone—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000338	0.000366	CcSEcCtD
Tolcapone—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000336	0.000365	CcSEcCtD
Tolcapone—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000336	0.000364	CcSEcCtD
Tolcapone—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000336	0.000364	CcSEcCtD
Tolcapone—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000335	0.000363	CcSEcCtD
Tolcapone—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000335	0.000363	CcSEcCtD
Tolcapone—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000335	0.000363	CcSEcCtD
Tolcapone—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000335	0.000363	CcSEcCtD
Tolcapone—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000334	0.000362	CcSEcCtD
Tolcapone—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000332	0.00036	CcSEcCtD
Tolcapone—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000332	0.00036	CcSEcCtD
Tolcapone—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000332	0.000359	CcSEcCtD
Tolcapone—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000332	0.000359	CcSEcCtD
Tolcapone—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.00033	0.000358	CcSEcCtD
Tolcapone—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.00033	0.000358	CcSEcCtD
Tolcapone—Rash—Vincristine—peripheral nervous system neoplasm	0.00033	0.000357	CcSEcCtD
Tolcapone—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000329	0.000357	CcSEcCtD
Tolcapone—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000329	0.000357	CcSEcCtD
Tolcapone—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000328	0.000356	CcSEcCtD
Tolcapone—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000328	0.000355	CcSEcCtD
Tolcapone—Headache—Vincristine—peripheral nervous system neoplasm	0.000328	0.000355	CcSEcCtD
Tolcapone—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000325	0.000352	CcSEcCtD
Tolcapone—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000323	0.00035	CcSEcCtD
Tolcapone—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000322	0.000349	CcSEcCtD
Tolcapone—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000316	0.000343	CcSEcCtD
Tolcapone—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000316	0.000342	CcSEcCtD
Tolcapone—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000315	0.000341	CcSEcCtD
Tolcapone—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000312	0.000338	CcSEcCtD
Tolcapone—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000312	0.000338	CcSEcCtD
Tolcapone—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000311	0.000337	CcSEcCtD
Tolcapone—Nausea—Vincristine—peripheral nervous system neoplasm	0.000311	0.000337	CcSEcCtD
Tolcapone—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.000336	CcSEcCtD
Tolcapone—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000309	0.000335	CcSEcCtD
Tolcapone—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000308	0.000333	CcSEcCtD
Tolcapone—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000307	0.000333	CcSEcCtD
Tolcapone—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.000331	CcSEcCtD
Tolcapone—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.00033	CcSEcCtD
Tolcapone—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000304	0.000329	CcSEcCtD
Tolcapone—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000303	0.000329	CcSEcCtD
Tolcapone—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000303	0.000328	CcSEcCtD
Tolcapone—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000301	0.000326	CcSEcCtD
Tolcapone—Chills—Epirubicin—peripheral nervous system neoplasm	0.0003	0.000325	CcSEcCtD
Tolcapone—Pruritus—Etoposide—peripheral nervous system neoplasm	0.0003	0.000325	CcSEcCtD
Tolcapone—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000299	0.000323	CcSEcCtD
Tolcapone—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000295	0.00032	CcSEcCtD
Tolcapone—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000294	0.000319	CcSEcCtD
Tolcapone—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000293	0.000317	CcSEcCtD
Tolcapone—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.000317	CcSEcCtD
Tolcapone—Rash—Cisplatin—peripheral nervous system neoplasm	0.000291	0.000316	CcSEcCtD
Tolcapone—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000291	0.000316	CcSEcCtD
Tolcapone—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00029	0.000314	CcSEcCtD
Tolcapone—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.000312	CcSEcCtD
Tolcapone—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000311	CcSEcCtD
Tolcapone—Tension—Epirubicin—peripheral nervous system neoplasm	0.000285	0.000309	CcSEcCtD
Tolcapone—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000285	0.000309	CcSEcCtD
Tolcapone—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000283	0.000306	CcSEcCtD
Tolcapone—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000304	CcSEcCtD
Tolcapone—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00028	0.000303	CcSEcCtD
Tolcapone—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.00028	0.000303	CcSEcCtD
Tolcapone—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.000302	CcSEcCtD
Tolcapone—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000277	0.000301	CcSEcCtD
Tolcapone—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.000299	CcSEcCtD
Tolcapone—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000275	0.000298	CcSEcCtD
Tolcapone—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000297	CcSEcCtD
Tolcapone—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000273	0.000296	CcSEcCtD
Tolcapone—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000271	0.000294	CcSEcCtD
Tolcapone—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.00027	0.000292	CcSEcCtD
Tolcapone—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000269	0.000292	CcSEcCtD
Tolcapone—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000269	0.000291	CcSEcCtD
Tolcapone—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000267	0.00029	CcSEcCtD
Tolcapone—Rash—Etoposide—peripheral nervous system neoplasm	0.000267	0.000289	CcSEcCtD
Tolcapone—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000267	0.000289	CcSEcCtD
Tolcapone—Headache—Etoposide—peripheral nervous system neoplasm	0.000265	0.000288	CcSEcCtD
Tolcapone—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000287	CcSEcCtD
Tolcapone—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000264	0.000286	CcSEcCtD
Tolcapone—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000264	0.000286	CcSEcCtD
Tolcapone—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000262	0.000284	CcSEcCtD
Tolcapone—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000283	CcSEcCtD
Tolcapone—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000261	0.000283	CcSEcCtD
Tolcapone—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000261	0.000283	CcSEcCtD
Tolcapone—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.00028	CcSEcCtD
Tolcapone—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000279	CcSEcCtD
Tolcapone—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000277	CcSEcCtD
Tolcapone—Cough—Epirubicin—peripheral nervous system neoplasm	0.000254	0.000275	CcSEcCtD
Tolcapone—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.000275	CcSEcCtD
Tolcapone—Nausea—Etoposide—peripheral nervous system neoplasm	0.000252	0.000273	CcSEcCtD
Tolcapone—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000251	0.000272	CcSEcCtD
Tolcapone—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.000271	CcSEcCtD
Tolcapone—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.00027	CcSEcCtD
Tolcapone—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000248	0.000268	CcSEcCtD
Tolcapone—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000248	0.000268	CcSEcCtD
Tolcapone—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000248	0.000268	CcSEcCtD
Tolcapone—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000247	0.000268	CcSEcCtD
Tolcapone—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000267	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000246	0.000267	CcSEcCtD
Tolcapone—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000245	0.000265	CcSEcCtD
Tolcapone—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000263	CcSEcCtD
Tolcapone—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000262	CcSEcCtD
Tolcapone—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000262	CcSEcCtD
Tolcapone—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.000262	CcSEcCtD
Tolcapone—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000259	CcSEcCtD
Tolcapone—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000258	CcSEcCtD
Tolcapone—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000237	0.000257	CcSEcCtD
Tolcapone—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000256	CcSEcCtD
Tolcapone—Infection—Epirubicin—peripheral nervous system neoplasm	0.000236	0.000256	CcSEcCtD
Tolcapone—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000255	CcSEcCtD
Tolcapone—Shock—Epirubicin—peripheral nervous system neoplasm	0.000234	0.000253	CcSEcCtD
Tolcapone—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000233	0.000252	CcSEcCtD
Tolcapone—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000232	0.000252	CcSEcCtD
Tolcapone—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000252	CcSEcCtD
Tolcapone—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000232	0.000251	CcSEcCtD
Tolcapone—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000231	0.00025	CcSEcCtD
Tolcapone—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.00023	0.000249	CcSEcCtD
Tolcapone—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000248	CcSEcCtD
Tolcapone—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000248	CcSEcCtD
Tolcapone—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000248	CcSEcCtD
Tolcapone—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000247	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000247	CcSEcCtD
Tolcapone—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000245	CcSEcCtD
Tolcapone—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000245	CcSEcCtD
Tolcapone—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000243	CcSEcCtD
Tolcapone—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000222	0.00024	CcSEcCtD
Tolcapone—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.00024	CcSEcCtD
Tolcapone—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.000238	CcSEcCtD
Tolcapone—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.000236	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000234	CcSEcCtD
Tolcapone—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000234	CcSEcCtD
Tolcapone—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000233	CcSEcCtD
Tolcapone—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000233	CcSEcCtD
Tolcapone—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000214	0.000232	CcSEcCtD
Tolcapone—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000231	CcSEcCtD
Tolcapone—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000213	0.000231	CcSEcCtD
Tolcapone—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.00023	CcSEcCtD
Tolcapone—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000212	0.000229	CcSEcCtD
Tolcapone—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000229	CcSEcCtD
Tolcapone—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.000227	CcSEcCtD
Tolcapone—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000226	CcSEcCtD
Tolcapone—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000206	0.000224	CcSEcCtD
Tolcapone—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000222	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000222	CcSEcCtD
Tolcapone—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000222	CcSEcCtD
Tolcapone—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000203	0.00022	CcSEcCtD
Tolcapone—Pain—Epirubicin—peripheral nervous system neoplasm	0.000203	0.00022	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000217	CcSEcCtD
Tolcapone—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000214	CcSEcCtD
Tolcapone—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000212	CcSEcCtD
Tolcapone—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000212	CcSEcCtD
Tolcapone—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000212	CcSEcCtD
Tolcapone—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000194	0.00021	CcSEcCtD
Tolcapone—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.00021	CcSEcCtD
Tolcapone—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.000207	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000206	CcSEcCtD
Tolcapone—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000205	CcSEcCtD
Tolcapone—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000204	CcSEcCtD
Tolcapone—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000204	CcSEcCtD
Tolcapone—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000204	CcSEcCtD
Tolcapone—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000203	CcSEcCtD
Tolcapone—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000203	CcSEcCtD
Tolcapone—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000196	CcSEcCtD
Tolcapone—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000195	CcSEcCtD
Tolcapone—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000175	0.00019	CcSEcCtD
Tolcapone—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000189	CcSEcCtD
Tolcapone—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000188	CcSEcCtD
Tolcapone—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000188	CcSEcCtD
Tolcapone—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000185	CcSEcCtD
Tolcapone—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000182	CcSEcCtD
Tolcapone—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000176	CcSEcCtD
Tolcapone—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000175	CcSEcCtD
Tolcapone—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000171	CcSEcCtD
Tolcapone—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000157	0.00017	CcSEcCtD
Tolcapone—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000168	CcSEcCtD
Tolcapone—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000164	CcSEcCtD
Tolcapone—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000163	CcSEcCtD
Tolcapone—Rash—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000162	CcSEcCtD
Tolcapone—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000162	CcSEcCtD
Tolcapone—Headache—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000161	CcSEcCtD
Tolcapone—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000157	CcSEcCtD
Tolcapone—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000153	CcSEcCtD
Tolcapone—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000151	CcSEcCtD
Tolcapone—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.00015	CcSEcCtD
Tolcapone—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.00015	CcSEcCtD
Tolcapone—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000149	CcSEcCtD
Tolcapone—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000141	CcSEcCtD
